Intravenous methylprednisolone reduces hospital stay for children with Multisystem Inflammatory Syndrome Dr Riya Dave6 Feb 2024 5:30 PM ISTIn the ongoing battle against the multifaceted impacts of COVID-19, the RECOVERY trial examined treatment approaches for Pediatric Multisystem...
Aflibercept increases retinal nonperfusion in eyes with proliferative diabetic retinopathy: Study Dr. Hiral patel12 Aug 2022 8:00 PM ISTTexas: Aflibercept 2mg, administered intravitreal monthly or quarterly resulted in a significant increase in retinal nonperfusion (RNP) in patients...
Casirivimab and imdevimab in patients admitted to hospital with COVID-19: RECOVERY Trial Dr. Kamal Kant Kohli9 March 2022 5:19 PM ISTCasirivimab and imdevimab are non-competing monoclonal antibodies that bind to two different sites on the receptor-binding domain of the SARS-CoV-2...
Convalescent Plasma Might not Benefit Hospitalised COVID Patients: Lancet MD Bureau18 May 2021 3:18 PM ISTDuring an epidemic caused by a novel virus, convalescent plasma is an appealing treatment because it might be available within weeks of the outbreak,...
No clinical benefit of lopinavir-ritonavir in hospitalised COVID-19 patients: RECOVERY TRIAL Dr. Kamal Kant Kohli30 Jun 2020 7:08 PM ISTStatement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on lopinavir-ritonavir, 29 June 2020In March...
